Accra, May 10, GNA - A two-day regional workshop for manufacturers of second line Tuberculosis medicines opened in Accra on Thursday with a call on participants to ensure that they obtained the World Health Organisation's (WHO) prequalification status.
The workshop, is being organised by Pharmacopeia of the United States with funding from US Agency International Development, is on the theme: 'Promoting the Quality of Medicines'.
It aims at educating manufacturers of second line medicines which is used to treat multi-resistant varieties of the Tuberculosis (TB) disease.
Dr Patrick Lukulay, Director Promoting the Quality of Medicine Programme (PQM), said the information from the workshop would enable the manufacturers to understand the WHO's prequalifying standards.
He said manufacturers, who participate in the programme and meet the prequalification standards, would be able to sell their products outside their home countries to the United Nations and the Global Fund, which together buy billions of dollars of medicines each year.
Dr Lukulay said products from manufacturers must be WHO prequalified or approved by a stringent regulatory authorities such as the US and Japanese Foods and Drug Agencies and the European FDA.
He said to facilitate manufacturers' access to the prequalification standards, PQM has been reaching out to potential manufacturers of the second line medicines in regions of the world with a high burden of TB.
Dr Lukulay said, the earlier the manufacturers work with PQM to prepare their dossier for the WHO Prequalification Programme, the better it would be for them to get the opportunity.
He said WHO minimum standards also helps companies meet international standards and in the process reduce the production of sub-standard products.